| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.17B | +7.0% |
| Cost of Revenue | $1.29B | +7.4% |
| R&D Expense | $195.7M | +6.9% |
| SG&A Expense | $830.4M | +20.3% |
| Operating Income | $802.6M | -2.9% |
| Interest Expense | $69.5M | -22.4% |
| Pre-tax Income | $754.9M | +0.0% |
| Income Tax | $112.2M | -4.1% |
| Net Income | $642.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $587.8M | +81.2% |
| Accounts Receivable | $828.8M | +13.0% |
| Inventory | $572.4M | +19.9% |
| Current Assets | $2.15B | +28.7% |
| Total Assets | $5.08B | +11.5% |
| Current Liabilities | $1.24B | +56.9% |
| Long-term Debt | $1.41B | -13.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $652.6M | -14.4% |
| Investing Cash Flow | -$152.3M | -5.7% |
| Financing Cash Flow | -$237.2M | +66.0% |
| +0.8% |
| EPS (Basic) | $10.80 | +0.5% |
| EPS (Diluted) | $10.76 | +0.5% |
| Total Liabilities |
| $2.52B |
| -7.7% |
| Stockholders' Equity | $2.56B | +40.1% |